In ruminants, prostaglandin F2 alpha (PGF 2alpha ) is synthesized and released in a pulsatile pattern from the endometrial luminal epithelial (LE) cells during the process of luteolysis. Interferon tau (IFNT) is a Type 1 IFN secreted by the trophoblast cells of the developing conceptus. IFNT acts locally on endometrial LE cells to inhibit pulsatile releases of PGF 2alpha and thus establish an endocrine environment for recognition of pregnancy. Cell signaling pathways through which IFNT stimulates expression of multiple genes or proteins in endometrial LE are largely unknown. Results of the present investigation indicate that intrauterine administration of IFNT inhibits pulsatile release of PGF 2alpha , while coadministration IFNT and ERK 1/2 inhibitor U0126 restores luteolytic PGF 2alpha pulses in sheep. IFNT increases phosphorylation of ERK1/2 proteins and increases its interaction with PGT proteins in endometrial LE. Blockade of ERK1/2 pathways inhibits IFNT action, decreases pERK1/2 and PGT protein interactions, and re-establishes the spatial expression of the oxytocin receptor protein completely and the estrogen receptor protein partially without modulating the expression of interferon regulatory factor-2 (IRF-2) protein in endometrial LE. IFNT does not decrease expression of COX-2, PGDH, or PGT protein in endometrial LE. Our results provide important new insights into IFNT signaling and the molecular endocrine control of PGF 2alpha release at the time of establishment of pregnancy in ruminants. This novel IFNT-ERK1/2 signaling module needs to be explored in future studies to understand molecular and cellular mechanisms of IFNT action in endometrial LE in ruminants.
INTRODUCTION
In ruminants, prostaglandin F2a (PGF 2a ) is the luteolytic hormone [1] . During the process of luteolysis, PGF 2a is synthesized and released from the endometrial luminal epithelial cells (LE) and superficial glandular epithelial cells (sGLE) in a pulsatile pattern that causes luteolysis. In sheep, continuous exposure of endometrium to progesterone (P4) for 8-10 days down-regulates expression of nuclear P4 receptor (PGR) in LE and sGLE cells between Days 11 and 13, thereby allowing a rapid increase in expression of nuclear estrogen receptor a (ESR1) after Day 13, followed by an increase in expression of membrane oxytocin receptor (OXTR) after Day 14 of the estrous cycle [1, 2] . Pulsatile releases of oxytocin from the posterior pituitary and corpus luteum (CL) after Days 13-14 of the estrous cycle acts via oxytocin receptors to induce release of luteolytic pulses of PGF 2a from LE and sGLE between Days 14 and 16 of the estrous cycle [1] . A minimum of five pulses of endometrial PGF 2a secreted over a period of 48 h are required to cause CL regression consistently in sheep [3] . Endometrial PGF 2a is transported into each adjacent uterine vein, which joins the adjacent ovarian vein to form the utero-ovarian vein. Luteolytic PGF 2a pulses are transported from the utero-ovarian vein into the ovarian artery locally through a unique vascular structure called the utero-ovarian plexus (UOP) [4] .
Cyclooxygenases COX-1 and COX-2 convert arachidonic acid into PGH 2 [5] . PGH 2 is then converted into PGF 2a by prostaglandin F synthases PGFS-AKR1B1 and PGFS-AKR1C3. Prostaglandin transporter (PGT) is a member of the 12-transmembrane solute carrier organic anion transporter (OATP) 2A1 (SLCO2A1) [6, 7] , which mediates cellular efflux and influx of PGF 2a [6] [7] [8] . PGT-mediated transport appears to involve an electrogenic anion exchange mechanism [6, 7, 9, 10] . We have reported in sheep that inhibition of PGT in the UOP at the time of luteolysis blocks the transport of PGF 2a from the utero-ovarian vein to ovarian artery [4] . Intrauterine inhibition of PGT blocks the pulsatile release of PGF 2a from the endometrium [11] .
During establishment of pregnancy in ruminants, interferon tau (IFNT), a Type 1 interferon secreted by the mononuclear cells of trophectoderm of the conceptus, acts on LE cells in a paracrine manner and suppresses transcription of ESR1 and OXTR genes [2, 12] and thereby inhibits oxytocin-induced pulsatile release of luteolytic PGF 2a by the endometrium. It is proposed that IFNT suppresses ESR1 and OXTR through interferon regulatory factor-2 (IRF-2) in endometrial LE cells in sheep [2, 13, 14] ; however, the direct interaction between IFNT signaling pathways and IRF2 in LE cells has yet to be documented. IFNT signaling is mediated through a cell surface receptor that is composed of two subunits IFNAR1 and IFNAR2. The well-characterized downstream signal transduction pathways of type I IFN is activation of tyrosine kinase 2 (TYK2) and Janus kinase 1 (JAK1) and signal transducer and activator of transcription (STAT), collectively known as the JAK/STAT pathways [15, 16] . Activation of JAK/STAT in turn regulates phosphorylation and activation of STATs and IFN-stimulated genes (ISGs). Phosphorylated STAT1 and STAT2 (heterodimers) together with interferon regulatory factor-9 (IRF-9) form IFN-stimulated gene factor 3 (ISGF3) transcriptional complex that translocates to the nucleus and binds with IFN-stimulated response elements (ISREs) to initiate transcription of specific ISGs. Interestingly, IFNAR1 and IFNAR2 genes are expressed [17] , but STAT1, STAT2, and IRF-9 genes are not expressed, in endometrial LE and sGLE cells at the time of recognition of pregnancy in sheep [12, 18] . On the other hand, IFNT-stimulated genes are expressed in LE cells [19] . This suggests that IFNT can apparently activate STAT-independent cell signaling pathways in endometrial LE cells at the time of establishment of pregnancy [12] .
We have recently identified novel mechanisms that IFNT activates JAK-SRC-EGFR-RAS-RAF-ERK-EGR-1 pathways in ovine endometrial luminal epithelial cells (oLE) and through which IFNT inhibits PGT-mediated release of PGF 2a from oLE cells in vitro [20] . Knockdown of ERK1/2 genes impaired interactions between IFNT, ERK1/2, and PGT proteins and IFNT was not able to inhibit the release of PGF 2a from oLE cells in vitro [20] . In the present study, we examined this novel mechanism in vivo in sheep. Our objectives were to 1) determine whether pharmacological inhibition of the ERK1/2 pathways restores pulsatile release of PGF 2a from the endometrium in IFNT-treated sheep and 2) identify the underlying molecular pathways in endometrial LE cells.
MATERIALS AND METHODS

Materials
The reagents used in this study were purchased from the following suppliers: PGT,COX- 
Animal Husbandry and Surgery
All experiments and surgical procedures were in accordance with the Guide for Care and Use of Agriculture Animals and approved by Texas A&M University's Laboratory Animal Care and Use Committee.
Study 1: ERK1/2 Inhibitor U0126 Dose-Response Experiment
Matured crossbred Suffolk ewes (Ovis aries) were observed daily for estrus in the presence of vasectomized rams that had exhibited at least two estrous cycles of normal duration (17-18 days). On Day 10 postestrus, the ewes underwent a midventral laparotomy. The lumen of the each uterine horn was catheterized with a vinyl catheter, and the tip of the catheter was placed 1 cm distal to the utero-tubal junction. The other end of the catheter was connected to preloaded and equilibrated Alzet 2ML1 Osmotic Pump (Durect Corporation, Cupertino, CA). The Alzet pump was then anchored to the broad ligament between the uterine horn and oviduct using cyanoacrylate glue (Super Glue, Bentonville, AR) and then secured by sewing the oviduct to the mesometrium and perimetrium of the uterine horn using #0 Vicryl-coated suture (Ethicon, Somerville, NJ) as we described previously [21] . The experimental ewes were randomly divided into four groups. Group 1 (n ¼ 4) control ewes received vehicle (2 ml, 3% DMSO Tris-buffer, pH 7.4), Group 2 (n ¼ 4) ewes received ERK1/2 inhibitor U0126 (0.125) in vehicle, and Group 3 (n ¼ 4) ewes received ERK1/2 inhibitor U0126 (0.5 mg) in vehicle through an Alzet osmotic pump from Days 10 to 16 of the estrous cycle. These doses for U0126 were based on the reported effective doses in experiments with rodents (0.2 mg/kg) [22] and pigs (0.25 mg/kg) [23] . The uteri of nonpregnant ewes weigh about 0.5 kg; therefore, the total dose (0.125 or 0.5 mg) was calculated on a per-kilogramuterine-weight basis. Jugular blood samples (3 ml) were collected daily from Day 11 to the day of estrus for measurement of P4 using a validated RIA. Estrus was determined using vasectomized rams.
Study 2: IFNT and ERK1/2 Interaction Experiment
Matured crossbred Suffolk ewes (O. aries) were observed daily for estrus in the presence of vasectomized rams that had exhibited at least two estrous cycles of normal duration (17-18 days). On Day 10 postestrus, the ewes underwent a midventral laparotomy. The lumen of the each uterine horn was catheterized by a vinyl catheter, and the tip of the catheter was placed 1 cm distal to the uterotubal junction. The other end of the catheter was connected to a preloaded and equilibrated Alzet 2ML1 Osmotic Pump (Durect Corporation) and fixed in the broad ligament as described above. The experimental ewes were randomly divided into four groups and received the following treatments through an Alzet osmotic pump from Days 10 to 16 of the estrous cycle. Group 1 control ewes (n ¼ 4) received ovine serum protein (200 lg) in vehicle, Group 2 ewes (n ¼ 4) received recombinant ovine IFNT (200 lg, equivalent to 2 3 10 7 AVU) in vehicle, Group 3 ewes (n ¼ 4) received IFNT (200 lg, equivalent to 2 3 10 7 AVU) and ERK1/2 inhibitor (U0126, 0.5 mg) in vehicle, and Group 4 ewes (n ¼ 4) received ERK1/2 inhibitor (U0126, 0.5 mg) in vehicle. Serum proteins and IFNT were prepared for intrauterine infusions as described previously [24, 25] . Intrauterine infusion of this amount of IFNT mimics the effects of the conceptus on endometrial expression of hormone receptors and IFNTstimulated genes during early pregnancy in ewes [24, 25] . Jugular venous blood samples were collected on Days 10 and 16 for P4 assay. Blood samples were collected hourly from 0700 h on Day 15 to 0700 h on Day 16 for PGFM assay. On Day 16, ewes were necropsied, and the uterus and ovary were collected.
Immunohistochemistry
Tissue sections were fixed in 4% Tris-buffered paraformaldehyde saline and processed using standard procedures. Paraffin sections (5 lm) were cut, and immunohistochemistry was performed using a Vectastain Elite ABC kit according to the manufacturer's protocols and as we described previously [4, 11, 20, 21] . Endogenous peroxidase activity was removed by fixing sections in 0.3% hydrogen peroxide in methanol. The tissue sections were blocked in 10% goat serum for 1 h at room temperature and incubated overnight at 48C with primary antibodies for ESR1 (1:200), OXTR (1:50), pERK1/2 (1:100), EGR-1 (1:100), PGT (1:250), COX-2 (1:250), or PGDH (1:500) at the concentration recommended by manufacturers. Then, tissue sections were further incubated with the secondary antibody (biotinylated IgG) for 45 min at room temperature. For the negative control, serum or IgG from respective species with reference to the primary antibody at their respective dilutions was used. Between each step, tissue sections were washed in PBS.
Digital images were captured using a Zeiss Axioplan 2 Research Microscope (Carl Zeiss; Thornwood, NY) with an Axiocam HR digital color camera. The intensity of staining for each protein was quantified using ImagePro Plus 6.3 image processing and analysis software according to the manufacturer's instructions (Media Cybernetics, Inc., Bethesda, MD). The detailed methods for quantification are given in the instruction guide ''The Image-Pro Plus: The Proven Solution for Image Analysis.'' In brief, six images of endometrial luminal epithelium (LE) at 4003 magnification were captured randomly without hot-spot bias in each tissue section per animal. Using the selection tools in the Image-Pro Plus software, LE was demarcated in the given sections, and the integrated optical intensity (IOD) of immunostaining was quantified under RGB mode. Numerical data were expressed as least square mean 6 SEM. This technique is more quantitative than conventional blind scoring systems, and the validity of the quantification was reported previously by our group [4, 11, 20, 21] .
Immunocytochemistry
Immunocytochemistry was performed according the protocol provided by Cell Signaling Technology (Danvers, MA). The uterine cryosections (10 lm) were fixed in 2% PFA for 15 min at room temperature and then fixed in methanol for 10 min at 48C. The tissue sections were incubated with rabbit polyclonal PGT (1:250) and mouse monoclonal p-ERK1/2 (1:200) primary antibodies for overnight at 48C. The sections were further incubated with Alexa fluor 488 goat anti-rabbit (1:100) and Alexa fluor 594 goat anti-mouse (1:100) secondary antibodies (Molecular Probes, Grand Island, NY) for 60 min at room temperature. Nuclei were stained with DAPI (ProLong Gold antifade; Molecular Probes). For the negative control, serum or IgG from respective species with reference to the primary antibody at the respective dilution was used. Microphotographs were captured using an image analysis work station as described above. Colocalization and interaction of PGT and ERK1/2 proteins LEE ET AL.
were quantified using Color composite and colocalization functions in the Image Pro-Plus 6.3 software. The colocalized pixels appear as orange to yellow, depending on the degree of colocalization toward the middle of the colocalization plot. Numerical values are expressed in Pearson correlation (R 2 ) colocalization coefficient according to the manufacturer's instructions.
ELISA
Concentrations of stable metabolite of PGF 2a (PGFM, 13,14-dihydro15keto PGF 2a ) were measured in plasma using a commercially available enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI) according to the manufacturer's instructions. Intra-assay coefficients of variation were determined at multiple time points on the standard curve as described by the manufacturer in each assay and compared between assays.
Progesterone Assay
Concentrations of P4 in plasma were determined using DSL-3900 ACTIVE Progesterone Coated-Tube RIA Kit according to the manufacturer's instructions (Diagnostic Systems Laboratories, Webster, TX). The RIA used rabbit antiprogesterone immunoglobulin-coated tubes and iodinated progesterone. The primary antiserum cross-reacts 6.0%, 2.5%, 1.2%, 0.8%, 0.48%, and 0.1% with 5a-pregnane-3, 20-dione, 11-deoxycorticosterone, 17a-hydroxyprogesterone, 5b-pregnane-3,20-dione, 11-deoxycortisol, and 20b-dihydroprogesterone, respectively. The P4 standard curve (0-10.57 ng/ml) was provided in the assay kit. The sensitivity or minimum detection limit of this assay is ;0.12 ng/ml. The intra-assay variation was 8.8%.
Statistical Analyses
Statistical analyses were performed using general linear models of Statistical Analysis System (SAS Institute Inc., Cary, NC). Effects of treatment, time, and treatment 3 time interactions on P4 concentrations (in vivo study 1) PGF 2a release (PGFM concentration, in vivo study 2) were analyzed by repeated measures for multivariate ANOVA. Comparison of means was tested by Wilks lambda or orthogonal contrast tests. Effects of treatments on the mean concentration of progesterone on Day 16 were analyzed by one-way ANOVA. Numerical data are expressed as mean 6 SEM. Statistical significance was considered as (P , 0.05). The statistical model accounted for sources of variation, including treatments, replicates, and ewes, as appropriate.
RESULTS
ERK1/2 Inhibitor U0126 Dose-Response Experiment and Effects on Estrous Cycle in Sheep
The experimental ewes received vehicle and ERK1/2 inhibitor (ERK-I) U0126 (0.125 or 0.5 mg in vehicle) through Alzet osmotic pump from Days 10-16 of the estrous cycle. Results (Fig. 1) indicated that all the ewes returned to estrus on the expected days, between Days 17 and 18. As expected, concentration of P4 decreased (P , 0.05) on Day 16 and reached basal level at estrus in all three groups. These results indicated that U0126 at both doses did not interfere with the normal luteolytic mechanisms in sheep. Therefore, U0126 at 0.5 mg was selected to determine interactions between IFNT and ERK1/2 pathways on pulsatile release of PGF 2a from the ovine endometrium.
Inhibition of ERK1/2 Restored the Luteolytic Pulsatile Release of PGF 2a from the Endometrium in IFNT-Treated Sheep
Experimental ewes were treated with intrauterine infusions of either vehicle, IFNT, IFNTþERK-I (U0126, 0.5 mg), or ERK-I from Days 10 to 16 of the estrous cycle. Beginning on Day 15, jugular blood samples were collected at a 1-h interval for 24 h, and the concentration of PGFM was measured in the plasma. In control sheep, three to four PGFM pulses with a mean amplitude of 1138 6 12 pg/ml at ;8-h intervals were detected between 0700 h on Day 15 and 0700 h on Day 16 ( Fig. 2A) . As expected in IFNT-treated sheep, these PGF 2a pulses were absent (P , 0.05), and the mean amplitude was only 75 6 7 pg/ml (Fig. 2B) . Importantly, cotreatment with ERK-I and IFNT inhibited IFNT actions and restored three to four PGF 2a pulses (P , 0.05) in the IFNTþERK-I group (Fig.  2C) . However, the mean amplitude of the PGFM pulse was slightly lower (P , 0.05) in the IFNTþERK-I group (1005 þ 11 pg/ml) compared to the control group (1138 þ 22 pg/ml). Sheep that received ERK-I exhibited three to four PGFM pulses with the mean amplitude of 1163 þ 42 pg/ml (Fig. 2D) , which was similar to the control group. In all experimental ewes, the concentration of P4 in the jugular venous plasma was 4.1-4.5 ng/ml on Day 10 of the estrous cycle. The concentration of P4 was maintained at 4.3 ng/ml in the IFNT-treated group but decreased to 1.7 ng/ml in the IFNTþERK-I-treated group. The concentration of P4 decreased to 1.1 and 1.2 ng/ml in the control and ERK-I-treated groups, respectively (Fig. 3) .
IFNT Induced the Phosphorylation of pERK1/2 and Expression of EGR-1 Proteins in Endometrial Luminal Epithelium in Sheep
Results (Fig. 4, panel 1 ) indicated that pERK1/2 and EGR-1 proteins were not expressed in LE but were abundantly expressed in stroma compactum of the endometrium on Day 16 of the estrous cycle. IFNT increased (P , 0.05) phosphorylation of pERK1/2 proteins (;10-fold) and expression of EGR-1 protein (;3-fold) in the endometrial LE but not in stroma on 
Inhibition of ERK1/2 Pathways Did Not Decrease Expression of COX-2, PGDH, and PGT Proteins in Endometrial Luminal Epithelium in IFNT-Treated Sheep
Results (Fig. 4, panel 3 ) indicated that COX-2, PGDH, and PGT proteins were abundantly expressed in endometrial LE. IFNT, IFNTþERK-I, or ERK-I did not decrease or increase the expressions of COX-2, PGDH, and PGT proteins in endometrial LE on Day 16 of the estrous cycle.
IFNT Increased the Interaction Between pERK1/2 and PGT Proteins in Endometrial Luminal Epithelium in Sheep
Colocalization and interaction between pERK1/2 and PGT proteins in the endometrial LE in vivo was performed (Fig. 5) . Immunocytochemistry results indicated that IFNT increased (P , 0.05) colocalization of pERK1/2 and PGT proteins, whereas ERK-I cotreatment with IFNT decreased (P , 0.05) colocalization of pERK1/2 and PGT proteins in endometrial LE in vivo. Colocalization scatter plot analysis indicated that IFNT increased (10-fold, P , 0.05) interaction between pERK1/2 and PGT proteins; by contrast, cotreatment with ERK-I with IFNT decreased (P , 0.05) such interaction between pERK1/2 and PGT proteins in endometrial LE in vivo.
DISCUSSION
Recent studies from our laboratory have established that in sheep 1) PGT protein is a final component of the luteolytic machinery that controls the release of luteolytic PGF 2a pulses from the endometrial LE into the uterine venous system [4, 11, 26] , 2) IFNT phosphorylates PGT protein at tyrosine and threonine and dephosphorylates PGT protein at serine residues, and 3) IFNT inhibits PGT-mediated release of PGF 2a through ERK1/2 pathways in endometrial LE cells in vitro [20] . In the present study, we inhibited ERK1/2 protein to identify a role for ERK1/2 pathways in IFNT downstream signaling and its association with PGT-mediated pulsatile release of PGF 2a in the ovine endometrium in vivo.
At the time of luteolysis in sheep, five to seven PGF 2a pulses are released from the endometrium between Days 14 and 16 of the estrous cycle [1, 27] . Recently, we have reported that a minimum of five pulses of PGF 2a in 48 h are necessary to consistently cause complete luteolysis in sheep [3] . Based on this, we expected that at least three PGF 2a pulses would occur at ;8-h intervals between Days 15 and 16 of the estrous cycle.
Results of the present study indicate that intrauterine infusion of IFNT between Days 10 and 16 of the estrous cycle completely suppresses the pulsatile release of PGF 2a from the endometrium; in contrast, cotreatment of ERK-I and IFNT inhibits the action of IFNT and restores three to four pulses of PGF 2a without modulating the expression of total PGT protein.
These results are in agreement with our previous data that IFNT does not decrease the expression of total PGT protein in endometrial LE in vivo [20] . In addition, the results indicate that inhibition of ERK1/2 did not modulate the expression of either the biosynthetic or the catabolic machinery of PGF 2a in the endometrium.
In deciphering novel IFNT signaling, we have recently discovered that IFNT activates JAK-SRC-EGFR-RAS-RAF-ERK1/2-EGR-1 signaling pathways in ovine endometrial luminal epithelial (oLE) cells in vitro [20] . Using oLE cell cultures and immunoprecipitation and ERK1/2 siRNA approaches, we have shown that IFNT phosphorylates the PGT protein at tyrosine and threonine residues, dephosphorylates the PGT protein at serine residues, and inhibits the PGT-mediated release of PGF 2a through ERK1/2 pathways. These findings from the in vitro experiments indicate that interaction between ERK1/2 and PGT are the important cell signaling cascades required to inhibit PGT-mediated pulsatile release of PGF 2a from the ovine endometrium [11, 20] . Therefore, we analyzed expression, colocalization, and interaction between pERK1/2 and PGT proteins in the endometrial LE in vivo. Results indicate that IFNT induces phosphorylation or activation of pERK1/2 and increases its interaction with PGT protein, while cotreatment with ERK-I and IFNT decreases the interaction between pERK1/2 and PGT protein in the endometrial LE in vivo. These results clearly indicate that IFNT interacts with PGT through ERK1/2 pathways and inhibits PGT-mediated release of PGF 2a from ovine endometrial LE in vivo. At this time, the molecular mechanism(s) through which ERK1/2 interacts with specific serine, threonine, and tyrosine residues of PGT is not clear. Indeed, unraveling these mechanisms will be the focus of future studies.
The present data indicate that IFNT inhibits up-regulation of ESR-1 and OXTR proteins in LE compared to controls, which is in agreement with previous well-established findings in sheep [2, 13, 14] . Concomitantly, IFNT increases phosphorylation of pERK1/2 proteins in LE cells in agreement with our previous finding [20] . The novel finding of the present study is that the restoration of PGF 2a pulses in the IFNT-and ERK-Itreated groups is positively associated with the expression of OXTR and ESR1 and negatively associated with the expression of ERK1/2 proteins in the endometrial LE. These results suggest important interactions among IFNT, ESR1, and OXTR through ERK1/2 pathways in endometrial LE in sheep. The underlying molecular pathways through which inhibition of ERK1/2 pathways re-establishes expression of OXTR and ESR1 are not known. Earlier studies have proposed that IFNT suppresses ESR1 and OXTR through an IRF2-dependent mechanism in endometrial LE [2, 13, 14] . However, the cell signaling pathways through which IFNT increases IRF-2 protein in endometrial LE is yet to be established. Our present results indicate that IFNT does not induce IRF-2 protein and cotreatment of ERK-I with IFNT does not modulate expression of IRF2 protein in endometrial LE on Day 16 of the estrous cycle. Early pioneering work by Bazer et al. [14] reported in one study that IFNT induced expression of IRF-2 protein in endometrial LE; in contrast, the same researchers reported in their next study that IFNT did not induce expression of IRF-2 protein in endometrial LE in cyclic sheep [18] . Taken together, our present results, along with the previous study [18] , strongly suggest that IFNT suppresses ESR1 and OXTR through novel mechanisms independent of IRF-2 pathways in endometrial LE at the time of establishment of pregnancy.
In a later study, Bazer et al. [28] have reported that IFNT precludes binding of ESR1/SP1 with GC-rich regions of the OXTR promoter and thereby indirectly inhibits transcription of OXTR genes through the ESR/SP1 complex. We have recently identified that IFNT activates JAK-SRC-EGFR-RAS-RAF-ERK1/2-EGR-1 novel signaling pathways in ovine endometrial epithelial cells in vitro [20] . The present investigation reports that IFNT increases pERK1/2 and EGR-1 proteins in endometrial LE in vivo. EGR-1 and SP1 are competing for the same GC-rich element, and EGR-1 acts as tissue-specific transcriptional suppressor or activator of various genes under different physiological and pathological conditions [29] [30] [31] . The interaction between this novel IFNT-ERK1/2-EGR-1 signaling module and ESR1-OXTR expression in the ovine endometrium is not confirmed in the present investigation; indeed, it will be our future focus.
Based on our present and previous results [20] and available information [18, [28] [29] [30] [31] , we proposed novel molecular mechanisms through which IFNT inhibits PGT-mediated release of PGF 2a and expression of OXTR and ESR1 in the ovine endometrial luminal epithelium in vivo, as illustrated in Figure 6 .
In conclusion, the novel findings of the present study are that 1) IFNT activates ERK1/2 pathways in endometrial LE and that inhibition of ERK1/2 pathways inhibits IFNT actions and restores endometrial luteolytic pulses of PGF 2a in sheep and that 2) the restoration of PGF 2a pulses in IFNT and ERK-I treated group is negatively associated with activation of 
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pERK1/2 proteins and its interaction with PGT protein and positively associated with expression of OXTR and ESR1 proteins in the endometrial LE. Importantly, these results add new information on IFNT signaling in endometrial LE in the ruminants.
